These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 2650060)
1. Class II antigen and interleukin-2 expression in renal allograft recipients. Nowaczyk M; Lao M; Maldyk M; Morzycka-Michalik M; Paczek L; Modlinska M; Gorski A Transplant Proc; 1989 Feb; 21(1 Pt 1):1002. PubMed ID: 2650060 [No Abstract] [Full Text] [Related]
2. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation. Barocci S; Valente U; Nocera A Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591 [TBL] [Abstract][Full Text] [Related]
3. Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody. Wilson JL; Proud G; Forsythe JL; Taylor RM; Kirby JA Transplantation; 1995 Jan; 59(1):91-7. PubMed ID: 7530869 [TBL] [Abstract][Full Text] [Related]
4. Class II antigens and interleukin 2 expression in renal allograft recipients. Glapinski T; Lao M; Wasik M; Lagodzinski Z; Nowaczyk M; Gorski A Transplant Proc; 1989 Feb; 21(1 Pt 1):319. PubMed ID: 2650133 [No Abstract] [Full Text] [Related]
5. Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients. Langley J; Dickerman R; Vergne-Marini P; Williams J; Jensik S; Kenyon N; Anderson J Transplant Proc; 1993 Feb; 25(1 Pt 2):939-43. PubMed ID: 8442275 [No Abstract] [Full Text] [Related]
6. Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells. Yoshimura N; Lee CJ; Shiho O; Kita M; Imanishi J; Oka T Transplant Proc; 1995 Feb; 27(1):390-1. PubMed ID: 7879033 [No Abstract] [Full Text] [Related]
7. T11+/DR+ lymphocytes in renal allograft recipients with irreversible rejection. Hayes JM; Valenzuela R; Novick AC; Steinmuller DR Transplantation; 1988 Apr; 45(4):806-9. PubMed ID: 2895969 [No Abstract] [Full Text] [Related]
8. Rapid immunodiagnosis of kidney rejection by using activation markers on kidney tubular cells and infiltrating T subset cells. Tötterman TH; Hanås E; Larsson E; Lindgren PG; Sjöberg O; Wahlberg J; Tufveson G Transplant Proc; 1987 Oct; 19(5):3570-1. PubMed ID: 3313860 [No Abstract] [Full Text] [Related]
9. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data. Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms in organ allograft rejection. An experimental and clinical study. Claesson K Scand J Urol Nephrol Suppl; 1987; 103():1-42. PubMed ID: 3321417 [TBL] [Abstract][Full Text] [Related]
11. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen. Maeda H; Ogoshi S; Fujimoto S Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685 [No Abstract] [Full Text] [Related]
12. Immunosuppression with an anti-IL-2 receptor monoclonal antibody in a baboon renal allograft model. Hayes JM; Spencer W; Valenzuela R; Caulfield M; Novick AC Transplant Proc; 1989 Feb; 21(1 Pt 1):1006-9. PubMed ID: 2650061 [No Abstract] [Full Text] [Related]
13. Macrophages and T lymphocytes expressing HLA-D region-encoded gene products in rejected renal transplants. Fellström B; Larsson E; Claesson K; Tufveson G; Wahlberg J; Klareskog L Transplant Proc; 1988 Jun; 20(3):372-4. PubMed ID: 3132767 [No Abstract] [Full Text] [Related]
14. HLA Class II-specific antibodies can react with T cells in flow cytometry crossmatch: a case report. Heo WB; Kim CD; Won DI Transplant Proc; 2007 Dec; 39(10):3485-7. PubMed ID: 18089415 [TBL] [Abstract][Full Text] [Related]
15. [Changes in class II (HLA-D) antigen expression on T-lymphocytes in the recipients of allogeneic kidney transplants]. Nowaczyk M; Małdyk-Durlik M; Morzycka-Michalik M; Modlińska M; Lao M; Górski A Pol Arch Med Wewn; 1988; 80(2-3):83-7. PubMed ID: 3271317 [No Abstract] [Full Text] [Related]
16. Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes. Allen CA; Hogg N Cancer Res; 1987 Jun; 47(11):2919-23. PubMed ID: 3105871 [TBL] [Abstract][Full Text] [Related]
17. T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation. Raskova J; Ghobrial I; Shea SM; Ebert EC; Eisinger RP; Raska K Diagn Immunol; 1986; 4(4):209-16. PubMed ID: 2944684 [TBL] [Abstract][Full Text] [Related]
18. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294 [TBL] [Abstract][Full Text] [Related]
19. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporine inhibits interleukin-2 production during human cellular immune response to pig antigens. Pozzetto U; Citterio F; Fioravanti G; Tassoni S; Serino F; Caizzi MP; Castagneto M Transplant Proc; 1994 Oct; 26(5):2869-70. PubMed ID: 7940906 [No Abstract] [Full Text] [Related] [Next] [New Search]